No Data
Express News | Summit Therapeutics - Entered Into Distribution Agreement Relating to Shares of Common Stock Offered by Prospectus Supplement
Express News | Summit Therapeutics Inc - May Offer and Sell Shares of Common Stock of up to $90 Mln From Time to Time
Summit Therapeutics Shares Are Trading Higher After Citigroup Initiated Coverage on the Stock With a Buy Rating.
Summit Therapeutics Shares Are Trading Higher After Citigroup Initiated Coverage on the Stock With a Buy Rating.
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply during Tuesday's session following upbeat quarterly ear
Summit Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/07/2024 53.51% Citigroup → $7 Initiates Coverage On → Buy 03/26/2024 75.44% Stifel → $8 Initiates Cover
Express News | Summit Therapeutics Inc : Citigroup Initiates Coverage With Buy Rating; Target Price $7